Next Gen Sequencing (NGS) Market | USD 17.15 Billion 2024 | CAGR Of 18.6%

11/gen/2019 14:19:42 PBIGP Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.


A Research Report On Next Generation Sequencing Market Comprising Of Market’s Current And Future Trends


The Next Gen Sequencing (NGS) Market Is Projected To Reach USD 17.15 Billion By 2024 From USD 5.13 Billion In 2017, At A CAGR Of 18.6% During The Forecast Period


Changing aspects of Next generation sequencing market

The global next generation sequencing market is growing due to following factors such as-

·         Increase in gene mapping activities

·         Affordable cost of sequencing and technological development in personalized medicine

·         Adding to this, rise in R & D activities by market players, drug discovery applications

However, dearth for skilled professionals, storage and management of patient data and ethical and legal issues related to the practices will hamper the next generation sequencing market.

 Request Sample Report :

Regional analysis:

North America is anticipated to hold the largest share due to increased R & D activities for proteomic and genomic sequence, rise in adoption of next generation sequence techniques is helping to grow the market. Moreover, countries such as U.S., U.K. and Germany which are offering courses related to molecular biology which is also help to grow the next generation sequence market.

Asia-Pacific is growing at faster rate in the global next generation sequencing market due to factors such as rising awareness about medical opportunities, increasing government initiatives and rise in partnerships and agreements among market players.

Market summary:

Local and international market players are actively involved in research, development and marketing of next generation sequencing market. Growing acquisitions, partnerships, collaborations and mergers are adopted by research laboratories and academic institutes and innovative products by market players are fueling the market of next-generation sequencing market.  In addition to this, scientists and drug developers are working towards development of personalized medicine in order to boost the next generation sequencing market. 

Notable market development:

Together with Amgen, Illumina’s next-generation sequencing cancer companion diagnostic test kit was FDA approved in 2017.


Some of the players in global next-generation sequencing market are

·         Agilent Technologies, Inc. (U.S.)

·         Illumina, Inc. (U.S.)

·         Pacific Biosciences (Danaher Corporation) (U.S.)

·         Thermo Fisher Scientific Inc. (U.S.)

·         Qiagen N. V. (Germany)

·         Beijing Genomics Institute (China)

·         PerkinElmer, Inc (U.S.)

·         F. Hoffmann La Roche AG (Switzerland)

·         Genomatix GmbH (Germany)

·         Oxford Nanopore Technologies (U.K.)

·         Eurofins Scientific (U.S.)


The global next generation sequencing market is divided into following categories-  

By product and service type

·         Pre-sequencing products and services market

o    DNA fragmentation, size selection, A-tailing, and end repair

o    Library preparation and target enrichment

o    Quality control

·         Sequencing services market

o    Targeted sequencing/gene panels

o    RNA-Seq

o    De Novo sequencing

o    Exome sequencing

o    Chip-Seq

o    Whole-genome sequencing

o    Methyl-Seq

o    others

·         Next-generationn sequencing, data analysis, storage, and management (Bioinformatics) market

o    NGS data analysis software & workbenches

o    NGS data analysis services

o    NGS storage management and cloud computing solutions


By technology

·         Ion semiconductor sequencing

·         Sequencing by the synthesis (SBS)

·         Nanopore sequencing

·         Single-molecule real-time (SMRT) sequencing


By application

·         Drug discovery

·         Diagnostics

·         Agriculture and animal research

·         Biomarker discovery

·         Precision medicine

·         Other applications


By end-users

·         Biotechnology and Pharmaceutical Companies

·         Research Centres

·         Hospitals & Clinics

·         Others


By geographical regions

·         North America

·         Latin America

·         Europe

·         Asia-Pacific

·         The Middle East & Africa



 For More Information:


blog comments powered by Disqus è un servizio offerto da Factotum Srl